An Indian multinational pharmaceutical company wanted to understand the treatment of various types of cardiometabolic disorders in the U.S.
The GLG Solution
GLG’s Research team facilitated a survey of 32 key opinion leaders (KOLs) in the U.S. to assess the treatment paradigm for cardiometabolic syndrome and other cardiometabolic disorders.
The KOLs that participated each had more than 20 years of experience in their field, and each treated over 80 patients with cardiometabolic indications specified per month using targeted product profile (TPP) drug combinations.
GLG’s research helped provide insight into the reasons behind the preference of prescribing different types of TPP. It drew out nuances such as how the KOLs understood safety and tolerance of patient profiles. This supported the client’s decision about the need for an injectable therapy in the management of cardiac patients.
GLG’s research supported the client’s objectives and understanding of the preference for a parenteral solution in the treatment landscape.
GLG Experts Engaged
GLG identified 32 healthcare industry KOLs in the U.S., matching them using patient profiles, volume, and treatment choices.
GLG provides clients with the specialized insights they’re seeking, either through experts already in the network, or by identifying who is needed and adding them to our global and growing network. For this project, GLG onboarded two KOLs with published work pertaining to the use of TPPs for the treatment.
Let us start helping you today
As the World’s Insight Network, GLG connects clients to the subject-matter experts who can provide real-world insights to make informed decisions. Our team of professionals work with you to create a tailored approach that identifies, assesses, and answers your questions on your timeline. We bring the power of insight to every great professional decision.